Gang Fang, PhD
- PROFESSOR | Genetics and Genomic Sciences
Research Topics:
Alzheimer's Disease, Cancer Genetics, Epigenetics, Genomics, Systems Biology, Translational ResearchDr. Fang is a Professor in the Department of Genetics and Genomic Sciences.
Lab page: Fang Lab @ Mount Sinai
Twitter: @iamfanggang
Long read sequencing of DNA and RNA;
Epigenetics of bacteria, microbiome and human;
Precision diagnosis and precision medicine
We are a “humid” lab where our members with diverse backgrounds use a combination of mindsets: technologies + experiments + computation, seamlessly. Our goal is to make fundamental discoveries in basic biology, and translate them into actionable diagnosis and therapeautics.
Multi-Disciplinary Training Areas
Artificial Intelligence and Emerging Technologies in Medicine [AIET], Genetics and Genomic Sciences [GGS]Education
BS, Fudan University
MS, University at Buffalo
PhD, University of Minnesota
-
2021
Maximizing Investigators' Research Award -
2018
Hirschl Research Scholar Award -
2017
Nash Family Scholar Award -
2012
Best Dissertation Award, University of Minnesota -
2010
Walter Barnes Lang Fellowship -
2010
Best Network Model Award, Sage Bionetworks -
2010
Young Scientist Award, Sage Congress -
2007
Mayo Clinic and IBM Research Fellowship
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Fang did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.